www.reportlinker.com
Open in
urlscan Pro
2606:4700:3037::ac43:ae08
Public Scan
Submitted URL: http://url9849.reportlinker.com/ls/click?upn=PNY3tIN1nBVCRfVXLm8fUeU2JCoALXmAgYqUB-2FMF-2FQQPRNrxNQo-2BsqQlbgnizlJvgm-2BTrUZuCsU...
Effective URL: https://www.reportlinker.com/p06381013/Hidradenitis-Suppurativa-HS-Marketed-and-Pipeline-Drugs-Assessment-Clinical-Trials-and...
Submission: On January 18 via manual from ES — Scanned from ES
Effective URL: https://www.reportlinker.com/p06381013/Hidradenitis-Suppurativa-HS-Marketed-and-Pipeline-Drugs-Assessment-Clinical-Trials-and...
Submission: On January 18 via manual from ES — Scanned from ES
Form analysis
4 forms found in the DOMName: frm_mdr_new — POST #
<form autocomplete="off" id="frm_mdr_new" name="frm_mdr_new" style="overflow:visible"
onsubmit="javascript:return search($('mot_cle_mdr').value, $('search_url').value, (($('search_page') && $('search_page').checked) || ($('search_page2') && $('search_page2').value)));" action="#" method="post">
<fieldset style="overflow:visible">
<div class="search-block">
<input id="mot_cle_mdr" name="mot_cle_mdr" type="text" placeholder="Search industry reports, statistics & slideshows" value="">
<input type="submit" class="search-zoom">
<input type="hidden" id="search_url" name="search_url" value="/report/search?keywords=REPLACE&mode=premium">
<input type="hidden" id="search_page2" name="search_page2" value="1">
</div>
</fieldset>
</form>
POST #
<form id="frm_search_inside" action="#" method="post" onsubmit="javascript: return frmSearchInside('search_keyword_new');">
<div>
<div class="big">
<input id="search_keyword_new" type="text" class="input-inside-search-360 grayer" placeholder="What are you looking for in this report?">
<span onclick="frmSearchInside('search_keyword_new');"></span>
</div>
<button class="new-sprite search-zoom" type="submit"></button>
</div>
</form>
POST #
<form id="search_zone" onsubmit="javascript:return search($('keyword_search').value, $('search_zone_url').value, 1);" method="post" action="#">
<fieldset>
<div class="search-block">
<input id="keyword_search" name="keyword_search" value="" type="text">
<input id="search_zone_url" name="search_zone_url" value="/report/search?keywords=REPLACE&mode=premium" type="hidden">
<input type="submit" value="" class="new-sprite search-zoom float-left" onclick="return search($('keyword_search').value, $('search_zone_url').value, 1);">
</div>
</fieldset>
</form>
<form id="PlpForm" onsubmit="javascript:return frmAddProduct('6381013')">
<fieldset>
<select id="plp-choice-license" name="choicelicence" onchange="changeLicense()" class="select-choice-license">
<option class="license" data-license-id="9" data-price="£3180" title="£3180 - 1 User License - PDF" selected="" data-has-immediate-delivery="1"> £3180 - 1 User License - PDF </option>
<option class="license" data-license-id="14" data-price="£6361" title="£6361 - Site License - PDF" data-has-immediate-delivery="1"> £6361 - Site License - PDF </option>
<option class="license" data-license-id="5" data-price="£9541" title="£9541 - Corporate License - PDF" data-has-immediate-delivery="1"> £9541 - Corporate License - PDF </option>
</select>
<div class="license-helper">
<span class="question-icon"></span>
<div class="explanation">
<ul>
<li><strong>Single User License</strong> — provides access to the report by one individual.</li>
<li><strong>Department License </strong> — allows you to share the report with up to 5 users</li>
<li><strong>Site License </strong> — allows the report to be shared amongst all employees in a defined country</li>
<li><strong>Corporate License </strong> — allows for complete access, globally.</li>
</ul>
</div>
</div>
<div id="plp-license-immediate-bloc" class="license-immediate-bloc">
<span class="picto-immediate"></span>
<span class="title_immediate">Immediate Delivery</span>
</div>
</fieldset>
<button class="clasic-green-bt txt-18" type="submit">Get Report</button>
<div class="plp-license-cta">
<button class="bot get-report-invoice-button" type="submit" value="invoice">Pay by invoice</button>
<button class="bot get-quote-button" type="button" onclick="DisplayForm(6381013,'Hidradenitis Suppurativa (HS) Marketed and Pipeline Drugs Assessment- Clinical Trials and Competitive Landscape','plp', null, 'quote')">Get a quote</button>
<button class="bot order-by-po" type="button" onclick="DisplayForm(6381013,'Hidradenitis Suppurativa (HS) Marketed and Pipeline Drugs Assessment- Clinical Trials and Competitive Landscape','plp', null, 'quote')">Order by PO </button>
<div class="license-helper">
<span class="question-icon"></span>
<div class="explanation">
<p> ReportLinker may already be registered as a supplier with your company. If you want to <strong>Order by PO</strong>, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise,
we'll provide you with the necessary information to register ReportLinker as a vendor. </p>
</div>
</div>
</div>
</form>
Text Content
* Login * My basket * EUR USD GBP 1. Home 2. > Healthcare 3. > Pathology Market Trends HIDRADENITIS SUPPURATIVA (HS) MARKETED AND PIPELINE DRUGS ASSESSMENT, CLINICAL TRIALS AND COMPETITIVE LANDSCAPE * December 2022 * 69 pages * ID: 6381013 * Format: PDF * GlobalData Summary Table of Contents Search Inside Hidradenitis Suppurativa (HS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HS therapeutics. Synopsis - In 2022, there will be more than three million diagnosed prevalent cases of HS across 16 pharmaceutical markets. - T only one FDA-approved medication, Humira (adalimumab), available for the treatment of HS, which is used in severe cases only. - A total of 57% of drugs in pipeline development for the treatment of HS are biologics. - Pfizer has sponsored the highest number of clinical trials (14 trials) in HS over the past 10 years. - During the past 12 months, there have been 11 mergers, acquisitions, and strategic alliances involving companies with HS assets. - Although there are high unmet needs in this indication, only two companies are developing therapies for HS that are in the late-stage pipeline. Scope Hidradenitis Suppurativa (HS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the report include - - Disease Landscape - Disease Overview - Epidemiology Overview - Treatment Overview - Marketed Products Assessment - Breakdown by Mechanism of Action, Molecule Type, Route of Administration - Product Profiles with Sales Forecast - Pricing and Reimbursement Assessment - Retail or Manufacturer Price of Products - Time to Pricing and Time to Reimbursement - Pipeline Assessment - Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration - Product Profiles with Sales Forecast - Late-to-mid-stage Pipeline Drugs - Phase Transition Success Rate and Likelihood of Approval - Clinical Trials Assessment - Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status - Enrolment Analytics, Site Analytics, Feasibility Analysis - Deals Landscape - Mergers, Acquisitions, and Strategic Alliances by Region - Overview of Recent Deals - Commercial Assessment - Key Market Players - Future Market Catalysts Reasons to Buy - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the HS market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global HS market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships. We are very sorry, but an error occurred. Please contact helpdesk@reportlinker.com if the problem remains. Our reports have been used by over 10K customers, including: Get Industry Insights. Simply. * Latest reports & slideshows with insights from top research analysts * 150+ Million searchable statistics with tables, figures & datasets * More than 25,000 trusted sources £3180 - 1 User License - PDF £6361 - Site License - PDF £9541 - Corporate License - PDF * Single User License — provides access to the report by one individual. * Department License — allows you to share the report with up to 5 users * Site License — allows the report to be shared amongst all employees in a defined country * Corporate License — allows for complete access, globally. Immediate Delivery Get Report Pay by invoice Get a quote Order by PO ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor. Grace helps you find the right report: * +44 207 1931 362 * Contact by email Testimonials The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future. Kate Merrick Global Marketing Manager at Eurotherm by Schneider Electric We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want. Category Manager at Ikea ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research. Executive Director at PwC Advisory The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker! Scott Griffith Vice President Marketing at Maurice Sporting Goods The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research Jessica P Huffman Research Associate at American Transportation Research Institute Excellent customer service. Very responsive and fast. Director, Corporate Strategy at Ingredion I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information. Mariana Mendoza Global Platform Senior Manager at Whirlpool Corporation Thanks! I like what you've provided and will certainly come back if I need to do further research works. Bee Hin Png CEO at LDR Pte Ltd The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future. Kate Merrick Global Marketing Manager at Eurotherm by Schneider Electric FAQ * How we can help * I am not sure if the report I am interested in will fulfill my needs. Can you help me? * Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements. * We buy reports often - can ReportLinker get me any benefits? * Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03. * I have had negative experiences with market research reports before. How can you avoid this from happening again? * We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you. * Report Delivery * How and when I will receive my Report? * Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees. * Payment conditions * What payment methods do you accept? * 1. Credit card : VISA, American Express, Mastercard, or 2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or 3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker * What are ReportLinker’s Payment Terms? * All payments must normally be submitted within 30 days. However, you can let us know if you need extended time. * Are Taxes and duties included? * All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge. * I’m not satisfied. Can I be refunded? * No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’. * User license * The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you. Purchase Reports From Reputable Market Research Publishers North America Intravenous Immunoglobulin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Form, and Application * £ 2730 * December 2022 * 166 pages North America Intravenous Immunoglobulin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Carmine, Anthocyanins, Caramel, Curcumin, Annatto, Carotenoids, Chlorophyll, and ... * North America * United States * Neurological Disorder * Autoimmune Disease * Industry analysis Self-injections Market Research Report by Type, Usage, Distribution Channel, Therapeutic Areas Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 £ 3594 October 2022 Psoriasis Drugs Market Research Report by Therapeutic Class, Type of Treatment, Mechanism of Action, Route of Administration, Distribution Channel, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 £ 3594 October 2022 Medical Aesthetics Market Research Report by Function, Treatment, Product, Operation, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 £ 3594 October 2022 Biologics Contract Manufacturing Market Research Report by Product, Platform, Therapeutic Area, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 £ 3594 October 2022 Global Ostomy Drainage Bags Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Regional Outlook and Forecast, 2022 - 2028 £ 3276 October 2022 Global Vanillin Market 2023-2027 £ 2275 December 2022 Middle East & Africa Intravenous Immunoglobulin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Form, and Application £ 2730 December 2022 Reiter’s Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 £ 4459 December 2022 Asia-Pacific Intravenous Immunoglobulin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Form, and Application £ 2730 December 2022 More Reports: Pathology in the World Pathology in Europe Pathology in Asia Pathology in North America Pathology in the United States Pathology in East Asia Pathology in Western Europe Pathology in Latin America Pathology in Southern Europe * Help Center * Terms & Conditions * Privacy Policy * Become a publisher * About us * Resources Center ref:plp2022 Reportlinker.com © Copyright 2023. All rights reserved. ReportLinker simplifies how Analysts and Decision Makers get industry data for their business. Make sure you don’t miss any news and follow us on By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.